Young Researchers Roundtable Breakfast

Thanks so much for joining us on Friday, October 4th for our breakfast event! Researcher presentations, event resources, and news coverage for the event are included below.

Presentations

Media Coverage

Special Announcement – New Support Group for MBC

Learn more about and resources for metastatic breast cancer today.

 


About the 2019 Event: Susan G. Komen® North Carolina Triangle to the Coast’s Young Researchers Roundtable Breakfast, presented by Pfizer Oncology, is a unique opportunity to connect early-career breast cancer researchers with established local Komen scholars, physicians, scientists, individuals living with metastatic breast cancer, breast cancer survivors, and co-survivors in a meaningful way.

For the third year, the breakfast will focus on Metastatic Breast Cancer (MBC) and will include presentations by individuals vested in MBC research and treatment. Young researchers will also have the opportunity to provide brief overviews of their breast cancer research projects. Alongside researcher presentations, there will be table discussions about breast cancer research and treatment and its impact on patient care. A Soda Float Social will follow the event to allow time for interested participants to connect and network beyond the roundtable discussions.

Friday, October 4, 2019
Washington Duke Inn | Durham, NC
9:15 AM – 12:30 PM

9:15 am – Doors open for registration and breakfast buffet
10:00 am – Welcome and Opening Remarks
10:15 am – Presentations and Roundtable Discussions
11:45 am – Closing Remarks
12:00 pm – Soda Float Social

Our goal is to move closer to finding the cures to breast cancer by encouraging open dialogue while developing a passionate, informed, and supportive community in the Triangle. #FindingSolutions

PROGRAM AGENDA

Welcome and Opening Remarks

Dr. Katherine  Hoadley, Assistant Professor, Department of Genetics, UNC Lineberger Comprehensive Cancer Center

“Hear My Voice” Special Announcment

Early Career Researcher Presentations

  • Susana Garcia Recio, The University of North Carolina at Chapel Hill
  • Hamzah Kharabsheh, Komen Graduate Training in Disparities Research Trainee, North Carolina Central University
  • Taylor Krebs, Duke University
  • Linnea Olsson, The University of North Carolina at Chapel Hill

New MBC Therapies

Dr. Charles Perou, The May Goldman Shaw Distinguished Professor of Molecular Oncology, UNC Lineberger Comprehensive Cancer Center

Supportive Care/Palliative Care for MBC

Dr. Anthony Galanos, Palliative Medicine Specialist, Duke Cancer Institute

Patient and Doctor Relationship

Dr. Sarah Sammons, Medical Oncologist, Duke Cancer Institute
Elizabeth Levene, Executive Director at Helps Education Fund and Living with MBC

Closing

Pam Kohl, Executive Director at Komen NCTC + Living with MBC
Katrina Cooke, advocate +  Living with MBC

Soda Float Social


What is Metastatic Breast Cancer (MBC)? Metastatic breast cancer is an advanced stage (stage IV) of breast cancer where tumor cells have spread to other parts of the body, such as the bones, liver, lungs or brain. Nearly all breast cancer deaths are due to MBC.

In the U.S., it’s estimated that at least 154,000 people have metastatic breast cancer. This year more than 42,000 women and men will die from breast cancer. Research is hope for those fighting metastatic breast cancer today, and for those who will be diagnosed tomorrow. Learn more about MBC.

 

Presented by:

 

Finding Solutions Logo Color